DESyne in Routine Clinical Practice (IRIS DESYNE)

Seung-Jung Park

Status: Terminated

Conditions: Coronary Artery Disease; Angioplasty, Transluminal, Percutaneous Coronary

Treatments: Device: DeSyne drug eluting stent group

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02039713

AMCCV2014-01

Details and patient eligibility

About

The purpose of this study is to evaluate effectiveness and safety of DESyne in Routine Clinical Practice

Enrollment: 342 patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 20 and more
• Intervention with DeSyne drug eluting coronary stent
• Agreed with written informed consent form

Exclusion criteria

• Intervention with DeSyne drug eluting coronary stent and other drug eluting stent at the same time
• Life expectancy of 1year and under
• Cardiac shock

Trial design

342 participants in 1 patient group

IRIS DeSyne

Description:

DeSyne drug eluting stent group

Treatment:

Device: DeSyne drug eluting stent group